pneumonia
major
caus
morbid
mortal
children
especi
develop
countri
diseas
account
approxim
two
million
death
per
year
death
children
mcintosh
sinanioti
sinanioti
due
signific
public
health
social
economi
develop
murphi
et
al
polverino
torr
marti
effect
measur
need
control
diseas
pneumonia
caus
varieti
microorgan
includ
bacteria
mycoplasma
virus
implement
bacteri
vaccin
pneumococc
conjug
vaccin
haemophilu
influenza
type
b
vaccin
immun
program
use
antibiot
pneumonia
effect
control
howev
concern
respiratori
virus
particularli
newli
identifi
one
rise
due
associ
pneumonia
ruuskanen
et
al
human
metapneumoviru
hmpv
rna
viru
member
pneumovirina
subfamili
paramyxovirida
famili
first
isol
children
acut
respiratori
tract
infect
netherland
van
den
hoogen
et
al
genom
organ
hmpv
similar
human
respiratori
syncyti
viru
rsv
van
den
hoogen
et
al
harbor
one
open
read
frame
orf
least
eight
viral
protein
lack
gene
hmpv
divid
four
subtyp
base
genet
analysi
sequenc
hmpv
isol
bastien
et
al
van
den
hoogen
et
al
huck
et
al
sinc
discoveri
hmpv
recogn
major
caus
lower
respiratori
tract
infect
children
worldwid
stockton
et
al
boivin
et
al
maggi
et
al
peiri
et
al
esper
et
al
mullin
et
al
william
et
al
et
al
caracciolo
et
al
kim
et
al
account
pediatr
pneumonia
case
depend
geograph
locat
year
subject
studi
lin
et
al
cilla
et
al
mathisen
et
al
wolf
et
al
et
al
although
pneumonia
lead
caus
death
children
less
year
old
china
rudan
et
al
etiolog
pneumonia
fulli
understood
sever
studi
report
overal
preval
hmpv
infect
children
china
ji
et
al
li
et
al
chen
et
al
xiao
et
al
investig
role
hmpv
pediatr
pneumonia
countri
studi
demograph
clinic
manifest
epidemiolog
featur
hmpv
infect
pediatr
patient
pneumonia
beij
evalu
hmpv
rna
nasopharyng
aspir
analysi
clinic
data
use
rsv
agent
pediatr
pneumonia
control
hmpv
subtyp
associ
pneumonia
also
assess
nasopharyng
aspir
npa
obtain
pediatr
patient
primari
diagnosi
pneumonia
upon
admiss
beij
children
hospit
juli
june
major
patient
year
old
although
age
rang
month
year
mean
age
month
median
age
month
male
femal
ratio
diagnosi
pneumonia
follow
guidelin
issu
chines
medic
associ
brief
pneumonia
clinic
defin
presenc
sign
symptom
pneumonia
caus
infect
acquir
outsid
hospit
work
group
respiratori
diseas
pediatr
societi
xiang
et
al
specimen
store
use
detail
demograph
clinic
present
laboratori
data
collect
clinic
record
variabl
studi
includ
age
sex
histori
congenit
heart
diseas
pneumonia
presenc
clinic
sign
symptom
maximum
temperatur
respiratori
rate
oxygen
satur
white
blood
cell
count
protein
concentr
studi
perform
complianc
human
experiment
guidelin
chines
ministri
health
viral
rna
extract
nasopharyng
aspir
use
nuclisen
easymag
platform
marci
franc
follow
manufactur
protocol
detect
identifi
four
subtyp
hmpv
specif
assay
target
p
gene
hmpv
perform
describ
previous
li
et
al
analysi
carri
use
superscript
iii
platinum
taq
kit
invitrogen
carlsbad
ca
pcr
product
analyz
electrophoresi
agaros
gel
stain
ethidium
bromid
bp
amplicon
clone
vector
takara
dalian
china
verifi
sequenc
analysi
hmpv
determin
align
pcr
sequenc
prototyp
strain
hmpv
includ
isol
subtyp
strain
genbank
access
strain
genbank
access
strain
genbank
access
strain
genbank
access
blast
http
blastncbinlmnihgovblastcgi
clustal
w
implement
dnastar
softwar
burland
hmpv
strain
assign
certain
subtyp
pcr
sequenc
show
highest
ident
prototyp
strain
specif
hmpv
subtyp
base
result
blast
clustal
w
addit
hmpv
respiratori
virus
includ
rsv
human
influenza
viru
human
parainfluenza
viru
adenoviru
rhinoviru
human
coronavirus
enteroviru
bocaviru
simultan
detect
use
multiplex
singl
describ
previous
ren
et
al
wang
et
al
associ
demograph
clinic
symptom
compar
differ
patient
group
use
test
anova
appropri
statist
analysi
perform
use
spss
version
spss
inc
chicago
il
p
valu
consid
signific
analysi
show
hmpv
rna
detect
pediatr
patient
pneumonia
male
femal
detect
rate
hmpv
lower
rhinoviru
respiratori
syncyti
viru
rsv
higher
respiratori
virus
includ
influenza
viru
adenoviru
parainfluenza
virus
human
coronaviru
human
bocaviru
enteroviru
data
indic
hmpv
play
import
role
pediatr
pneumonia
beij
patient
rang
age
month
year
mean
age
month
median
age
month
hmpv
detect
significantli
higher
rate
patient
age
month
age
month
p
patient
age
month
repres
subject
studi
account
patient
tabl
respiratori
virus
detect
patient
patient
mainli
rsv
n
rhinoviru
n
respiratori
virus
includ
influenza
viru
parainfluenza
viru
adenoviru
human
coronaviru
human
bocaviru
enteroviru
also
tabl
ii
detect
rate
hmpv
fluctuat
year
fig
detect
rate
hmpv
significantli
higher
p
contrast
detect
rate
rsv
fluctuat
significantli
remain
constant
respect
p
nucleotid
analysi
partial
p
gene
show
patient
posit
tabl
detect
although
domin
hmpv
subtyp
studi
period
observ
studi
year
octob
novemb
decemb
march
wherea
februari
form
epidem
peak
late
autumn
earli
spring
studi
year
observ
januari
wherea
observ
march
june
form
small
epidem
peak
spring
earli
summer
fig
case
detect
august
septemb
april
decemb
character
clinic
featur
pneumonia
caus
hmpv
clinic
manifest
case
compar
exclud
interfer
case
singl
hmpv
rsv
infect
evalu
similar
rsv
infect
fever
cough
expector
rhinorrhea
wheez
swell
tonsil
major
symptom
observ
patient
pneumonia
tabl
iii
signific
differ
major
clinic
manifest
gender
ratio
histori
pneumonia
congenit
heart
diseas
laboratori
data
eg
white
blood
cell
count
hemoglobin
oxygen
satur
patient
howev
proport
singl
hmpv
infect
significantli
lower
vs
p
singl
rsv
infect
children
month
old
n
studi
hmpv
subtyp
well
hmpv
clinic
epidemiolog
characterist
associ
pediatr
pneumonia
beij
analyz
result
show
hmpv
play
import
role
pediatr
pneumonia
beij
china
hmpv
infect
account
case
juli
june
hmpv
detect
lower
rate
beij
studi
popul
less
year
old
israel
wolf
et
al
studi
popul
less
year
old
spain
cilla
et
al
howev
hmpv
detect
rate
beij
higher
report
brazil
children
younger
year
old
et
al
also
higher
nepal
children
less
year
old
mathisen
et
al
taiwan
china
children
less
year
old
lin
et
al
variabl
rate
hmpv
detect
may
attribut
variat
climat
locat
popul
studi
similar
previou
studi
lin
et
al
cilla
et
al
wolf
et
al
found
patient
pneumonia
posit
hmpv
respiratori
virus
patient
rsv
rhinoviru
higher
rate
previous
report
observ
patient
studi
instanc
rate
hmpvrsv
israel
wolf
et
al
spain
cilla
et
al
reason
differ
unclear
could
attribut
differ
detect
method
direct
immunofluoresc
assay
dfa
tissu
cultur
method
use
studi
israel
wolf
et
al
wherea
pcr
method
differ
method
employ
use
studi
spain
cilla
et
al
studi
detect
bacteria
respiratori
sampl
carri
detect
use
evid
infect
respiratori
sampl
bogaert
et
al
although
might
pneumonia
case
studi
bacteri
pathogen
except
affect
major
find
describ
base
sequenc
analysi
partial
p
gene
hmpv
three
hmpv
subtyp
detect
studi
period
consist
previou
studi
cilla
et
al
frequent
detect
subtyp
pediatr
patient
pneumonia
detect
studi
also
found
patient
lower
respiratori
tract
infect
data
shown
result
agre
previou
report
tianjin
china
li
et
al
korea
chung
et
al
contrast
taiwan
china
februari
februari
wang
et
al
brazil
januari
decemb
oliveira
et
al
four
hmpv
subtyp
detect
patient
lower
respiratori
tract
infect
anoth
report
gansu
provinc
china
decemb
novemb
detect
xiao
et
al
wherea
chongq
china
april
march
detect
chen
et
al
taken
togeth
find
studi
report
suggest
preval
hmpv
subtyp
vari
among
differ
geograph
locat
long
term
surveil
hmpv
infect
need
better
understand
distribut
hmpv
subtyp
prevent
possibl
outbreak
inform
vaccin
develop
summari
detect
rate
hmpv
rank
third
patient
pneumonia
similar
clinic
manifest
observ
patient
find
indic
hmpv
play
signific
role
pediatr
pneumonia
china
find
also
provid
better
understand
epidemiolog
clinic
featur
hmpv
infect
